Cleared Traditional

K834262 - TRANS-PACE

K834262 is an FDA 510(k) clearance for TRANS-PACE, manufactured by Micromedical Devices, Inc.. The device is a Class 2 Cardiovascular device with product code DRO cleared through the Traditional 510(k) pathway after a 58-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1984
Decision
58d
Days
Class 2
Risk

K834262 is an FDA 510(k) clearance for the TRANS-PACE. Classified as Pacemaker, Cardiac, External Transcutaneous (non-invasive) (product code DRO), Class II - Special Controls.

Submitted by Micromedical Devices, Inc. (Mchenry, US). The FDA issued a Cleared decision on February 4, 1984 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5550 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Micromedical Devices, Inc. devices

FDA 510(k) Submission Details - K834262

510(k) Number K834262 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 08, 1983
Decision Date February 04, 1984
Days to Decision 58 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 125d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRO Device Classification - Class 2, Special Controls

Product Code DRO Pacemaker, Cardiac, External Transcutaneous (non-invasive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRO Pacemaker, Cardiac, External Transcutaneous (non-invasive)

All 57
Devices cleared under the same product code (DRO) and FDA review panel - the closest regulatory comparables to K834262.
PACE AID MODEL 53
K844811 · Cardiac Resucitator Corp. · Jan 1985
PACE *AID MODEL 52
K843547 · Cardiac Resucitator Corp. · Dec 1984
HEART-AID MODEL 80
K843358 · Cardiac Resucitator Corp. · Nov 1984
LIFEPAK 7D
K840047 · Physio-Control Corp. · Feb 1984
LIFEPAK 7P
K832876 · Physio-Control Corp. · Jan 1984
PACE* AID MODEL 50
K820507 · Cardiac Resucitator Corp. · Aug 1982